Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Maternal corticosteroid use and orofacial clefts.

Carmichael SL, Shaw GM, Ma C, Werler MM, Rasmussen SA, Lammer EJ; National Birth Defects Prevention Study.

Am J Obstet Gynecol. 2007 Dec;197(6):585.e1-7; discussion 683-4, e1-7.

PMID:
18060943
2.

Use of anti-asthmatic drugs during pregnancy. 3. Congenital malformations in the infants.

Källén B, Otterblad Olausson P.

Eur J Clin Pharmacol. 2007 Apr;63(4):383-8. Epub 2007 Feb 6.

PMID:
17279357
3.

Correlates of intake of folic acid-containing supplements among pregnant women.

Carmichael SL, Shaw GM, Yang W, Laurent C, Herring A, Royle MH, Canfield M; National Birth Defects Prevention Study.

Am J Obstet Gynecol. 2006 Jan;194(1):203-10.

4.

Maternal asthma, preeclampsia and risk of hypospadias.

Sørensen HT, Pedersen L, Nørgaard M, Wogelius P, Rothman KJ.

Epidemiology. 2005 Nov;16(6):806-7. No abstract available.

PMID:
16222172
5.

Corticotropin-releasing hormone (CRH) and urocortin act through type 1 CRH receptors to stimulate dehydroepiandrosterone sulfate production in human fetal adrenal cells.

Sirianni R, Mayhew BA, Carr BR, Parker CR Jr, Rainey WE.

J Clin Endocrinol Metab. 2005 Sep;90(9):5393-400. Epub 2005 Jul 12.

PMID:
16014403
6.

The potential influence of maternal stress hormones on development and mental health of the offspring.

Weinstock M.

Brain Behav Immun. 2005 Jul;19(4):296-308. Epub 2004 Nov 19. Review.

PMID:
15944068
7.

Corticotropin-releasing hormone directly stimulates cortisol and the cortisol biosynthetic pathway in human fetal adrenal cells.

Sirianni R, Rehman KS, Carr BR, Parker CR Jr, Rainey WE.

J Clin Endocrinol Metab. 2005 Jan;90(1):279-85. Epub 2004 Oct 19.

PMID:
15494460
8.

In utero prednisone exposure affects genital development.

Yucel S, Desouza A, Baskin LS.

J Urol. 2004 Oct;172(4 Pt 2):1725-30; discussion 1730.

PMID:
15371800
9.

Toward the effective surveillance of hypospadias.

Dolk H, Vrijheid M, Scott JE, Addor MC, Botting B, de Vigan C, de Walle H, Garne E, Loane M, Pierini A, Garcia-Minaur S, Physick N, Tenconi R, Wiesel A, Calzolari E, Stone D.

Environ Health Perspect. 2004 Mar;112(3):398-402.

10.

Hypospadias in California: trends and descriptive epidemiology.

Carmichael SL, Shaw GM, Nelson V, Selvin S, Torfs CP, Curry CJ.

Epidemiology. 2003 Nov;14(6):701-6.

PMID:
14569186
11.

Induction of cleft palate in mice by cortisone and its reduction by vitamins.

PEER LA, BRYAN WH, STREAN LP, WALKER JC Jr, BERNHARD WG, PECK GC.

J Int Coll Surg. 1958 Aug;30(2):249-54. No abstract available.

PMID:
13575880
12.

Guidelines for case classification for the National Birth Defects Prevention Study.

Rasmussen SA, Olney RS, Holmes LB, Lin AE, Keppler-Noreuil KM, Moore CA; National Birth Defects Prevention Study.

Birth Defects Res A Clin Mol Teratol. 2003 Mar;67(3):193-201.

PMID:
12797461
13.

The National Birth Defects Prevention Study.

Yoon PW, Rasmussen SA, Lynberg MC, Moore CA, Anderka M, Carmichael SL, Costa P, Druschel C, Hobbs CA, Romitti PA, Langlois PH, Edmonds LD.

Public Health Rep. 2001;116 Suppl 1:32-40.

14.

High-dose pyridoxine as an 'anti-stress' strategy.

McCarty MF.

Med Hypotheses. 2000 May;54(5):803-7.

PMID:
10859691
15.

Normal development of the male anterior urethra.

van der Werff JF, Nievelstein RA, Brands E, Luijsterburg AJ, Vermeij-Keers C.

Teratology. 2000 Mar;61(3):172-83.

PMID:
10661906
17.
18.

Ontogeny of the male urethra: theory of endodermal differentiation.

Kurzrock EA, Baskin LS, Cunha GR.

Differentiation. 1999 Jan;64(2):115-22.

PMID:
10234808
19.

International trends in rates of hypospadias and cryptorchidism.

Paulozzi LJ.

Environ Health Perspect. 1999 Apr;107(4):297-302.

20.

Population-based case-control study of teratogenic potential of corticosteroids.

Czeizel AE, Rockenbauer M.

Teratology. 1997 Nov;56(5):335-40.

PMID:
9451758

Supplemental Content

Support Center